Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


New research looks at "dog breath

New research looks at the benefit of BLIS K12™ probiotic in dogs

BLIS Technologies Ltd (NZX:BLT) announces the successful completion of the first phase in a research programme, which focuses on preventing bad breath in dogs. According to the programme leader at BLIS Technologies, Dr John Hale the BLIS K12™ probiotic, which is already known for its ability to inhibit bacteria responsible for the severe bad breath in humans, has been given to dogs to determine if bad breath can be reduced or eliminated in companion animals.

“The trial was a pilot study to determine the viability of the BLIS K12™ probiotic in a dog’s mouth, using either a liquid and solid dose form” Hale said. “The results from this small pilot trial were encouraging enough to commence a longer, extended dosing trial in dogs, which started in Dunedin last week”

The study was made possible through collaboration between BLIS Technologies and the Otago Polytechnic School of Veterinary Nursing, where many of the staff have volunteered their own dogs for the trial. BLIS Technologies has already undertaken bench-top studies in their own laboratory and found that their BLIS K12™ probiotic was able to inhibit around 50% of the various bacteria of a dog’s mouth and this is a big part of the reason why the Company has undertaken these trials in dogs.

Bacterial infections of the teeth and gums in dogs and cats are increasing problem, according to the veterinary industry and while BLIS Technologies is currently just focused on bacterial bad breath in dogs, it is hoped that the Company could eventually expand its research into the animal periodontal area.

"This research represents further evidence that the BLIS K12™ probiotic is a highly versatile organism and plays an important role in the Company’s commercial strategy " said Dr Barry Richardson, Chief Executive of BLIS Technologies. "We believe that this early data points to a beneficial effect in dogs and we would expect further studies to confirm this effect before commercialization in the animal market."


© Scoop Media

Business Headlines | Sci-Tech Headlines


Air New Zealand: Flying Year-round To Popular Queensland Destinations

Air New Zealand is moving to year-round direct flights on its Auckland-Cairns, Auckland-Sunshine Coast and Christchurch-Gold Coast routes under an agreement with the Queensland Government... More>>

SEA: Another First For Solar Energy In New Zealand

The Sustainable Energy Association NZ (SEANZ) congratulates Sunergise on the commissioning of the Sunergise Kapuni Solar Power Plant, the largest in the country... More>>

Accenture: More Boomers Than Zoomers Want To Work From Home

While often associated with tech savvy Gen Z or Zoomers, new global research from Accenture shows that the push for more flexible working environments is being led by Gen Xers and Baby Boomers... More>>

Banking: Westpac New Zealand To Remain Part Of Westpac Group

Westpac New Zealand Limited (WNZL) remains part of Westpac Group following a decision for the two businesses not to demerge. Westpac Group Chief Executive Officer, Peter King, said: “After a detailed review, we believe a demerger of the WNZL business would not be in the best interests of shareholders... More>>

Mercury: Enters Into Binding Agreements To Acquire Trustpower’s Retail Business

Mercury NZ Limited (Mercury) has announced that it has entered into binding agreements with Trustpower Limited (Trustpower, NZX:TPW) to acquire Trustpower’s retail business for NZ$441 million... More>>


ASB: New Zealanders Missing Out On Hundreds Of Millions In KiwiSaver Government Contributions

New Zealanders have just over a week to ensure they’re eligible for the maximum annual government KiwiSaver contribution... More>>